# Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

> **NCT01301040** · PHASE2 · TERMINATED · sponsor: **Jules Bordet Institute** · enrollment: 2 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** epirubicin, cyclophosphamide, docetaxel

## Key facts

- **NCT ID:** NCT01301040
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03
- **Primary completion:** 2013-03
- **Final completion:** 2016-03
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2013-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301040, "Early Cardiac Toxicity of Adjuvant CT in Elderly BC.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01301040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*